These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21072531)

  • 1. Management of punding in Parkinson's disease: an open-label prospective study.
    Fasano A; Ricciardi L; Pettorruso M; Bentivoglio AR
    J Neurol; 2011 Apr; 258(4):656-60. PubMed ID: 21072531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amantadine may reverse punding in Parkinson's disease--observation in a patient.
    Kashihara K; Imamura T
    Mov Disord; 2008 Jan; 23(1):129-30. PubMed ID: 17960816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose quetiapine for drug induced dyskinesias in Parkinson's disease: a double blind cross over study.
    Katzenschlager R; Manson AJ; Evans A; Watt H; Lees AJ
    J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):295-7. PubMed ID: 14742609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Punding on L-dopa.
    Fernandez HH; Friedman JH
    Mov Disord; 1999 Sep; 14(5):836-8. PubMed ID: 10495047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity.
    Pettorruso M; Fasano A; De Risio L; Ricciardi L; Di Nicola M; Martinotti G; Janiri L; Bentivoglio AR
    J Neurol Sci; 2016 Mar; 362():344-7. PubMed ID: 26944176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into pathophysiology of punding reveal possible treatment strategies.
    Fasano A; Petrovic I
    Mol Psychiatry; 2010 Jun; 15(6):560-73. PubMed ID: 20489735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence and clinical characteristics of punding in Parkinson's disease.
    Spencer AH; Rickards H; Fasano A; Cavanna AE
    Mov Disord; 2011 Mar; 26(4):578-86. PubMed ID: 21648123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease.
    Fernandez HH; Friedman JH; Jacques C; Rosenfeld M
    Mov Disord; 1999 May; 14(3):484-7. PubMed ID: 10348474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Amantadine for the treatment of levodopa dyskinesias in Parkinson's disease].
    Cersósimo MG; Scorticati MC; Micheli FE
    Medicina (B Aires); 2000; 60(3):321-5. PubMed ID: 11050808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies.
    Fernandez HH; Trieschmann ME; Burke MA; Friedman JH
    J Clin Psychiatry; 2002 Jun; 63(6):513-5. PubMed ID: 12088163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotyped behaviors or punding after quetiapine administration in Parkinson's disease.
    Miwa H; Morita S; Nakanishi I; Kondo T
    Parkinsonism Relat Disord; 2004 Mar; 10(3):177-80. PubMed ID: 15036174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quetiapine for l-dopa-induced psychosis in PD.
    Weiner WJ; Minagar A; Shulman LM
    Neurology; 2000 Apr; 54(7):1538. PubMed ID: 10751276
    [No Abstract]   [Full Text] [Related]  

  • 13. Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis.
    Morgante L; Epifanio A; Spina E; Zappia M; Di Rosa AE; Marconi R; Basile G; Di Raimondo G; La Spina P; Quattrone A
    Clin Neuropharmacol; 2004; 27(4):153-6. PubMed ID: 15319699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Three patients with Parkinson's disease whose therapeutic levels were successfully improved after administration of quetiapine for suppression of psychosis].
    Kodama R; Morita S; Miwa H; Kondo T
    No To Shinkei; 2003 May; 55(5):413-7. PubMed ID: 12833883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quetiapine-Induced extrapyramidal side effects in patients with Parkinson's disease: case report.
    Sommer BR
    J Geriatr Psychiatry Neurol; 2001; 14(2):99-100. PubMed ID: 11419575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of quetiapine at low doses on psychosis motor disability and stress of the caregiver in patients with Parkinson's disease].
    Giménez-Roldán S; Navarro E; Mateo D
    Rev Neurol; 2003 Mar 1-15; 36(5):401-4. PubMed ID: 12640589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Punding and dyskinesias.
    Silveira-Moriyama L; Evans AH; Katzenschlager R; Lees AJ
    Mov Disord; 2006 Dec; 21(12):2214-7. PubMed ID: 17013916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex repetitive behavior: punding after bilateral subthalamic nucleus stimulation in Parkinson's disease.
    Pallanti S; Bernardi S; Raglione LM; Marini P; Ammannati F; Sorbi S; Ramat S
    Parkinsonism Relat Disord; 2010 Jul; 16(6):376-80. PubMed ID: 20346726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of quetiapine in Parkinson's patients with psychosis.
    Targum SD; Abbott JL
    J Clin Psychopharmacol; 2000 Feb; 20(1):54-60. PubMed ID: 10653209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine improves psychotic symptoms and cognition in Parkinson's disease.
    Juncos JL; Roberts VJ; Evatt ML; Jewart RD; Wood CD; Potter LS; Jou HC; Yeung PP
    Mov Disord; 2004 Jan; 19(1):29-35. PubMed ID: 14743357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.